Journal of Aerosol Medicine and Pulmonary Drug Delivery, known for its high editorial standards and transparent review process, is the only authoritative journal delivering innovative articles on the health effects of inhaled aerosols and delivery of drugs through the pulmonary system. The Journal is a forum for leading experts, addressing novel topics such as aerosolized chemotherapy, aerosolized vaccines, methods to determine toxicities, and delivery of aerosolized drugs in the intubated patient.
Journal of Aerosol Medicine and Pulmonary Drug Delivery coverage includes:
- Pulmonary drug delivery
- Airway reactivity and asthma treatment
- Inhalation of particles and gases in the respiratory tract
- Toxic effects of inhaled agents
- Aerosols as tools for studying basic physiologic phenomena
Journal of Aerosol Medicine and Pulmonary Drug Delivery is under the editorial leadership of Editor Gerald C. Smaldone, MD, PhD, Pulmonary, Critical Care and Sleep Division, School of Medicine, State University of New York at Stony Brook and other leading investigators. View the entire editorial board.
Audience: Respiratory specialists, pulmonary specialists, internal medicine specialists, pharmaceutical researchers, and equipment manufacturers, among others.
The Official Journal of the International Society for Aerosols in Medicine.
ISAM members: Access the full online text via the “Members Only” page.
The views, opinions, findings, conclusions and recommendations set forth in any Journal article are solely those of the authors of those articles and do not necessarily reflect the views, policy or position of the Journal, its Publisher, its editorial staff or any affiliated Societies and should not be attributed to any of them.